Back
ESC Premium Access

Atrial fibrillation burden and the risks of ischemic stroke and intracranial hemorrhage: comparisons of catheter ablation, medical therapy, and non-atrial fibrillation population

Session: Atrial Fibrillation-Related Stroke: the Features Worth Clinician’s Attention
Topic: Rhythm Control, Catheter Ablation
Speaker: Assistant Professor M. Kim (Cheongju, KR)
Event: ESC Congress 2020

Congress Presentation

About the speaker

Assistant Professor Min Kim

Chungbuk National University Hospital, Cheongju (Korea (Republic of))
0 follower

5 more presentations in this session

Temporal relationship between atrial fibrillation and ischaemic stroke in a large cohort with continuous rhythm monitoring

Speaker: Doctor D. Singer (Boston, US)

Access
Abstract
Slides
Thumbnail

Relationship of aging and incident comorbidities to stroke risk in 594,169 Patients with atrial fibrillation: a nationwide analysis

Speaker: Professor L. Fauchier (Tours, FR)

Access
Abstract
Slides
Thumbnail

Risk of ischemic stroke in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis

Speaker: Professor L. Fauchier (Tours, FR)

Access
Abstract
Slides
Thumbnail

Plasma natriuretic peptide level is an independent determinant of major clinical outcomes in atrial fibrillation patients without heart failure: The Fushimi AF Registry

Speaker: Doctor Y. Hamatani (Kyoto, JP)

Access
Abstract
Slides
Thumbnail

The effect of body mass index on clinical outcomes in patients with newly diagnosed atrial fibrillation in the GARFIELD-AF registry

Speaker: Doctor C. Camm (Oxford, GB)

Access
Abstract
Slides
Thumbnail

Access the full session

Atrial Fibrillation-Related Stroke: the Features Worth Clinician’s Attention

Speakers: Assistant Professor M. Kim, Doctor D. Singer, Professor L. Fauchier, Professor L. Fauchier, Doctor Y. Hamatani...
Access
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb